Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized comparison of Dianeal versus Physioneal in incident automated peritoneal dialysis patients
2008-005242-23Phase 4Recruiting
- Sponsor
- Hospital Universitario de Gran Canaria Dr. Negrín
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of calcium chloride and Physioneal in end-stage kidney disease (ESKD) (2 arms), sponsored by Hospital Universitario de Gran Canaria Dr. Negrín. Primary endpoints: Primary efficacy endpoint and Peritoneal transport and membrane integrity assessment. Started Jan 2009; status: recruiting.
02
Drugs
calcium chloridePhysioneal
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2008-005242-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005242-23.